Skip to content

Alethia Malaria 480925

by Meridian Bioscience Inc.

Ref 480925

Alethia Malaria 480925 is a multiple Plasmodium species nucleic acid IVD (EU IVDR Class C; FDA Class II; FDA product code OAX, Plasmodium Spp. Detection Reagents) made by Meridian Bioscience Inc., registered in EUDAMED on 15 Sep 2026 (Basic UDI-DI 008407331ALETHIACLC008RR) and listed in FDA GUDID since 26 Oct 2020 (UDI-DI 00840733102240), active as of 8 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number008407331ALETHIACLC008RR Basic UDI-DI 00840733102240UDI-DIDate15 Sep 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00840733102240 UDI-DI Date26 Oct 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
The Alethia Malaria amplification assay, performed on the Alethia Incubator/Reader, is a qualitative in vitro diagnostic test for the direct detection of Plasmodium sp. DNA in human venous EDTA whole blood specimens from individuals with signs and symptoms of malarial infection. Results from Alethia Malaria assays are intended to be used as an aid in the diagnosis of human malaria infection. Alethia Malaria assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect Plasmodium sp. DNA by targeting segments of the Plasmodium genome. Alethia Malaria assay does not distinguish between Plasmodium species. Alethia Malaria is intended for use in hospital, reference or state laboratory settings. The device is not intended for nonlaboratory point-of-care use.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 8 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 008407331ALETHIACLC008RR registered 15 Sep 2026 Active
  • FDA GUDID UDI-DI 00840733102240 listed 26 Oct 2020 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00840733102240
  2. Registered EUDAMED 008407331ALETHIACLC008RR

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
alethia® Malaria EUDAMED
Alethia Malaria GUDID
Generic name
Multiple Plasmodium species nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
480925
Primary DI / UDI-DI
00840733102240
Basic UDI-DI
008407331ALETHIACLC008RR
Direct marketing DI
00840733102240
FDA product code
OAX
EMDN code
W0105050209 Plasmodium (malaria)
GMDN term
Multiple Plasmodium species nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class C EUDAMED
Class II GUDID
Regulation number
866.3402
EU registration type
Standard device
EU market of registration
Italy
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class C
GUDID
Class II

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under PLASMODIUM (MALARIA).

Other devices from Meridian Bioscience Inc.

See all devices from Meridian Bioscience Inc. →

Properties

  • Single use
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)